UNIVERSITE CATHOLIQUE DE L'OUEST ASSOCIATION SAINT YVES

Their core work

UCO is a French Catholic university in Angers contributing specialist academic expertise in nanosafety and engineered nanomaterial risk assessment to large European research consortia. Their work centers on developing regulatory-grade frameworks for grouping and classifying nanomaterials by hazard, and applying computational toxicology tools — including physiologically-based pharmacokinetic (PBPK) models, QSAR, and systems biology — to predict nanomaterial behavior without animal testing. They contribute the scientific rigor needed to translate nanomaterial safety research into actionable regulatory standards and industrial safe-by-design practice. Despite modest individual funding, their participation in two flagship EU nanosafety programs places them within a broad European network working to define how nanomaterials are regulated.

What they specialise in

How they've shifted over time

In their first project (NanoREG II, 2015–2019), UCO's focus was squarely on regulatory practice: developing grouping methodologies, demonstrating safe-by-design tools, and building standards that industry and regulators could apply directly. Moving into NanoInformaTIX (2019–2023), the emphasis shifted toward computational and in-silico methods — multi-scale material modelling, PBPK, QSAR, and systems biology — with a clear goal of reducing animal experiments through predictive informatics. The trajectory is from regulatory demonstration toward computational toxicology, reflecting the broader EU nanosafety field's move to replace wet-lab testing with validated models.

UCO is deepening into computational approaches to nanomaterial safety — making them a relevant partner for projects that need PBPK/QSAR modelling expertise or that must demonstrate regulatory compliance without animal testing.

How they like to work

UCO participates exclusively as a consortium partner and has never led a project — their role is that of a specialist contributor bringing a defined scientific competency rather than coordinating large programs. Both their projects were conducted within large RIA consortia, which explains the unusually high partner count (70 partners across 24 countries) relative to just two projects. Working with UCO means engaging a focused academic team within a shared multi-partner context, not a project management hub.

UCO's two projects collectively involved 70 unique consortium partners across 24 countries, reflecting participation in large pan-European nanosafety programs rather than a bilateral network of their own. Their reach is genuinely European in scope, though it is consortium-driven rather than independently cultivated.

What sets them apart

UCO occupies a specific niche at the intersection of nanosafety regulation and computational toxicology — a combination that is directly relevant to the EU's push for animal-free chemical and nanomaterial safety assessment. As a Catholic university with an applied science orientation, they bring academic credibility without the overhead or competing priorities of a large research university. For a consortium that needs a credible academic voice on nanomaterial grouping or PBPK modelling, UCO offers focused expertise that larger generalist partners rarely provide with the same depth.

Highlights from their portfolio

• NanoREG II
  Flagship EU nanosafety regulatory project; UCO's participation positioned them at the table where grouping methodologies and safe-by-design standards for nanomaterials were defined for the entire European regulatory framework.
• NanoInformaTIX
  Marks UCO's transition into computational toxicology, contributing to a modelling platform that integrates PBPK, QSAR, and systems biology to replace animal testing in nanomaterial safety evaluation.